
GACC has simplified filing for imported-food importers and exporters while strengthening port verification, change reporting and ongoing supervision.

Beijing's pilot allows companies to download and print approved import clearance documents digitally, reducing paperwork while maintaining existing regulatory requirements.

China has introduced GMP inspection guidelines for sterile, implantable, IVD, custom-made denture and standalone software medical devices.

India’s CDSCO releases final medical device software guidance under MDR 2017, outlining licensing routes, software risk classes, and cybersecurity standards.

Singapore’s HSA has revised GN-15 medical device registration guidance, updating submission templates, SaMD requirements and post-market expectations.

Find out which imported veterinary biological products need updated testing, revised registration standards, or regulatory approval before May 2027.

Indonesia extends halal certification deadlines for medicines, medical devices, cosmetics, and other regulated products, giving additional time to meet compliance requirements.

Discover the eight efficacy categories, revised filing requirements, and key compliance deadlines that toothpaste manufacturers and importers must meet.

See how China’s new battery registration guidance affects technical documentation, supplier coordination, and NMPA review of active implantable medical devices.

China's CMDE guidance defines clinical trial and registration considerations for implantable BCI devices, including patient selection, endpoints, and post-market follow-up.

Learn how China’s proposed measures could affect market exclusivity for pediatric and rare disease drugs, including eligibility, filing timelines, and supply obligations.

Indonesia has updated the categories, product types and risk classes used for IVD medical devices. Learn what this means for new and existing authorizations.

The announcement sets tighter thresholds, testing mandates, and exemption pathways for foreign brands selling cosmetics and toothpaste in China.

New medical device GMP inspection guidelines introduce revised inspection criteria and risk classifications.

New Indonesian guidelines impact SaMD, SiMD, and AI medical devices, introducing updated documentation and clinical validation rules.

China’s 2026–2030 pharmaceutical plan sets ambitious targets to turn its biopharma sector into a global innovation engine, reshaping international competition, licensing, and regulation.

Plan ahead for Malaysia NPRA’s 2026 year-end payment closure, featuring key deadlines for QUEST3+ online transactions and the Revenue Counter.

China’s latest policy sets new requirements for hospital medicine catalogs, prescribing practices, clinical evaluation, and performance-linked funding

Vietnam’s Decision No. 3046/QĐ-BYT expands CSDT appraisal capacity for medical devices.

Learn how Vietnam’s Apostille Decree may affect medical device registration and cosmetic product notification, including CFS, LOA, and document legalization requirements.
No articles match that combination. Try a different category or market.
And discover how we can support your needs across Asia-Pacific.